Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma

Background Elevated bile amylase level in patients with pancreaticobiliary maljunction (PBM) or high confluence of pancreaticobiliary ducts (HCPBD) is well known as a risk factor for gallbladder carcinoma (GBC) development. However, the effects of occult pancreaticobiliary reflux (OPR), a condition...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepato-biliary-pancreatic sciences 2017-02, Vol.24 (2), p.103-108
Hauptverfasser: Fujimoto, Takaaki, Ohtsuka, Takao, Nakashima, Yohei, Gotoh, Yoshitaka, Date, Kenjiro, Mori, Yasuhisa, Sadakari, Yoshihiko, Takahata, Shunichi, Oda, Yoshinao, Nakamura, Masafumi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Elevated bile amylase level in patients with pancreaticobiliary maljunction (PBM) or high confluence of pancreaticobiliary ducts (HCPBD) is well known as a risk factor for gallbladder carcinoma (GBC) development. However, the effects of occult pancreaticobiliary reflux (OPR), a condition characterized by high bile amylase level in the presence of an anatomically normal pancreaticobiliary junction, on GBC development remain unclear. The aim of this study was to assess the relationship between OPR and GBC. Methods Clinicopathological data of 52 patients who were preoperatively diagnosed with gallbladder (GB) tumor (22 malignant, 30 benign) were retrospectively reviewed. All of the patients underwent preoperative endoscopic retrograde cholangiopancreatography to evaluate pancreaticobiliary junction morphology and bile amylase level. The relationship between the histological diagnosis of GB lesions, and pancreaticobiliary junction morphology and bile amylase level were investigated. Results Pancreaticobiliary maljunction, HCPBD, and normal pancreaticobiliary junction (NPJ) were identified in 12, nine, and 31 patients, respectively. The rates of GBC in patients with PBM, HCPBD, and NPJ were 58% (7/12), 67% (6/9), and 29% (9/31), respectively. Of the 31 patients with NPJ, 22 had OPR and nine of these had GBC. None of the patients with NPJ and normal bile amylase level had GBC. Additionally, among patients with NPJ, bile amylase level was significantly higher in patients with GBC than in patients with benign tumors. Conclusions Occult pancreaticobiliary reflux, like PBM and HCPBD, is a risk factor for GBC development. HighlightFujimoto and colleagues demonstrate that elevation of bile amylase levels in the presence of an anatomically normal pancreaticobiliary junction, indicating occult pancreaticobiliary reflux, is, like pancreaticobiliary maljunction, a risk factor for the development of gallbladder carcinoma. Assessment of bile amylase levels in addition to pancreaticobiliary junction morphology may be important.
ISSN:1868-6974
1868-6982
DOI:10.1002/jhbp.421